The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East

Background and aimLittle is known about the burden of cardiorenal syndrome (CRS) and cardiorenal anemia syndrome (CRAS) in the Middle East Region. Furthermore, whether the occurrence rates of CRAS differ across heart failure (HF) phenotypes is not widely investigated. We aimed to examine the prevale...

Full description

Bibliographic Details
Main Authors: Yosef Manla, Obada Kholoki, Feras Bader, Oshin Kanwar, Emna Abidi, Wasim S. El Nekidy, Fadi Hijazi, Nizar Attallah
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1244275/full
_version_ 1797688027656486912
author Yosef Manla
Yosef Manla
Obada Kholoki
Feras Bader
Oshin Kanwar
Emna Abidi
Emna Abidi
Wasim S. El Nekidy
Fadi Hijazi
Nizar Attallah
author_facet Yosef Manla
Yosef Manla
Obada Kholoki
Feras Bader
Oshin Kanwar
Emna Abidi
Emna Abidi
Wasim S. El Nekidy
Fadi Hijazi
Nizar Attallah
author_sort Yosef Manla
collection DOAJ
description Background and aimLittle is known about the burden of cardiorenal syndrome (CRS) and cardiorenal anemia syndrome (CRAS) in the Middle East Region. Furthermore, whether the occurrence rates of CRAS differ across heart failure (HF) phenotypes is not widely investigated. We aimed to examine the prevalence of CRS and CRAS in patients with HF, compare characteristics of patients with CRAS-HFrEF vs. CRAS-HFpEF, and investigate anemia association with 1-year all-cause hospitalizations.MethodsHF patients who visited a multidisciplinary HF clinic at a single center between 10-2015 and 06-2022 (n = 968) were retrospectively included. Differences in rates of CRAS prevalence, and patients’ characteristics of those with CRAS-HFrEF vs. CRAS-HFpEF were determined using appropriate testing methods. Generalized estimating equation (GEE) models were used to determine if anemia was associated with higher rates of hospitalization.ResultsCRS was prevalent in 34.4% of subjects, while 25.3% had CRAS. CRAS prevalence rates among patients with HFpEF vs. HFrEF were comparable (27.2% vs. 24.2%, p = 0.3). Compared to patients with HFrEF-CRAS, those with HFpEF-CRAS were more likely females (p < 0.001), had a higher burden of hypertension (p = 0.01), and lower hemoglobin (p = 0.02). In an adjusted GEE model, anemia was associated with an average increase of 1.8 admissions in CRS patients (p = 0.015).ConclusionIn patients with HF, 1 in 3 patients presented with CRS, and 1 in 4 patients had CRAS. The prevalence of CRAS was comparable among those HFpEF and HFrEF. Anemia was associated with an increased rate of 1-year all-cause hospitalization in CRS patients.
first_indexed 2024-03-12T01:26:27Z
format Article
id doaj.art-99d58d681d6f4314ad236c3da94f9a23
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-03-12T01:26:27Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-99d58d681d6f4314ad236c3da94f9a232023-09-12T18:15:37ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-09-011010.3389/fcvm.2023.12442751244275The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle EastYosef Manla0Yosef Manla1Obada Kholoki2Feras Bader3Oshin Kanwar4Emna Abidi5Emna Abidi6Wasim S. El Nekidy7Fadi Hijazi8Nizar Attallah9Department of Cardiology, Heart, Vascular, and Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesResearch Department, Academic Office, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesDepartment of Cardiology, Heart, Vascular, and Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesDepartment of Cardiology, Heart, Vascular, and Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesResearch Department, Academic Office, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesResearch Department, Academic Office, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesDepartment of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesDepartment of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesDepartment of Nephrology, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesDepartment of Nephrology, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesBackground and aimLittle is known about the burden of cardiorenal syndrome (CRS) and cardiorenal anemia syndrome (CRAS) in the Middle East Region. Furthermore, whether the occurrence rates of CRAS differ across heart failure (HF) phenotypes is not widely investigated. We aimed to examine the prevalence of CRS and CRAS in patients with HF, compare characteristics of patients with CRAS-HFrEF vs. CRAS-HFpEF, and investigate anemia association with 1-year all-cause hospitalizations.MethodsHF patients who visited a multidisciplinary HF clinic at a single center between 10-2015 and 06-2022 (n = 968) were retrospectively included. Differences in rates of CRAS prevalence, and patients’ characteristics of those with CRAS-HFrEF vs. CRAS-HFpEF were determined using appropriate testing methods. Generalized estimating equation (GEE) models were used to determine if anemia was associated with higher rates of hospitalization.ResultsCRS was prevalent in 34.4% of subjects, while 25.3% had CRAS. CRAS prevalence rates among patients with HFpEF vs. HFrEF were comparable (27.2% vs. 24.2%, p = 0.3). Compared to patients with HFrEF-CRAS, those with HFpEF-CRAS were more likely females (p < 0.001), had a higher burden of hypertension (p = 0.01), and lower hemoglobin (p = 0.02). In an adjusted GEE model, anemia was associated with an average increase of 1.8 admissions in CRS patients (p = 0.015).ConclusionIn patients with HF, 1 in 3 patients presented with CRS, and 1 in 4 patients had CRAS. The prevalence of CRAS was comparable among those HFpEF and HFrEF. Anemia was associated with an increased rate of 1-year all-cause hospitalization in CRS patients.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1244275/fullcardiorenal anemia syndromecardiorenal syndromeheart failureMiddle Eastchronic kidney disease
spellingShingle Yosef Manla
Yosef Manla
Obada Kholoki
Feras Bader
Oshin Kanwar
Emna Abidi
Emna Abidi
Wasim S. El Nekidy
Fadi Hijazi
Nizar Attallah
The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East
Frontiers in Cardiovascular Medicine
cardiorenal anemia syndrome
cardiorenal syndrome
heart failure
Middle East
chronic kidney disease
title The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East
title_full The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East
title_fullStr The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East
title_full_unstemmed The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East
title_short The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East
title_sort prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all cause hospitalizations a retrospective single center study from the middle east
topic cardiorenal anemia syndrome
cardiorenal syndrome
heart failure
Middle East
chronic kidney disease
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1244275/full
work_keys_str_mv AT yosefmanla theprevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT yosefmanla theprevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT obadakholoki theprevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT ferasbader theprevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT oshinkanwar theprevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT emnaabidi theprevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT emnaabidi theprevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT wasimselnekidy theprevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT fadihijazi theprevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT nizarattallah theprevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT yosefmanla prevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT yosefmanla prevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT obadakholoki prevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT ferasbader prevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT oshinkanwar prevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT emnaabidi prevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT emnaabidi prevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT wasimselnekidy prevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT fadihijazi prevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast
AT nizarattallah prevalenceofcardiorenalanemiasyndromeamongpatientswithheartfailureanditsassociationwithallcausehospitalizationsaretrospectivesinglecenterstudyfromthemiddleeast